Nearest Resistance: N/A
Nearest Support: $23.75Catalyst: Earnings, IPO, Phase III Results First up today is Pfizer (PFE), the drugmaking giant that's known for blockbuster drugs like Celebrex, Lipitor and Viagra. Pfizer announced its second-quarter earnings this morning, besting Wall Street's expectations thanks to cost cutting efforts. It was an action-packed morning for Pfizer. On top of earnings, the firm announced that it had received positive phase III results from one of its pipeline rheumatoid arthritis drugs and that it was planning to file in mid-August to IPO its animal health unit. The deal will unload around 20% of Pfizer's stake of the subsidiary. >>22 Biopharma Stocks With Breakout Potential The news sent Pfizer to a new 52-week high in this morning's trading, a good sign for shareholders. Making new highs is significant from an investor psychology standpoint because it means that everyone who has bought shares in the last year is sitting on gains - as a result, the "back to even" mentality is less of a concern than it would be for a name with a higher proportion of shareholders sitting on losses. For late-to-the-game buyers though, I'd recommend sitting on the sidelines until PFE pushes above today's high water mark. Pfizer, as of the most recently reported period, is one of Ken Fisher's top holdings.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV